NURO Past Earnings image   This NURO past earnings page last updated 7/25/2022
NURO Past Earnings
PeriodPast Earnings DateGAAP
Q2 20227/21/2022-0.170
Q1 20224/26/2022-0.140
Q4 20211/27/2022-0.150
Q3 202110/21/2021-0.120
Q2 20217/22/2021-0.130
Q1 20214/22/2021-0.020
Q4 20201/28/2021-0.090
Q3 202010/22/2020-0.070
Q2 20207/23/2020-0.250
Q1 20204/23/2020-0.500
Q4 20191/27/2020-1.080
Q3 201910/17/2019-1.400
Q2 20197/18/2019-3.700
Q1 20194/25/20191.500
Q4 20181/24/2019-3.800
Q3 201810/17/20181.500
Q2 20187/19/20180.800
Q1 20184/19/20181.600
Q4 20171/25/2018-12.300
Q3 201710/19/2017-16.500
Q2 20177/20/2017-25.500
Q1 20174/20/2017-32.000
Q4 20161/26/2017-41.600
Q3 201610/20/2016-60.800
Q2 20167/21/2016-73.600
Q1 20164/21/2016-80.000
Q4 20151/28/2016-19.200
Q3 201510/22/2015-83.200
Q2 20157/22/2015-153.600
Q1 20154/21/2015-80.000
Q4 20142/12/2015-115.200
Q3 201410/28/2014-60.800
Q2 20147/24/2014-272.000
Q1 20144/24/2014-67.200
Q4 20132/13/2014-412.800
Q3 201310/23/2013-80.000
Q2 20137/25/2013-294.400
Q1 20134/25/2013-339.200
Q4 20122/19/2013-284.800
NURO Past Revenue
PeriodPast Earnings DateGAAP
Q2 20227/21/20220.00B
Q1 20224/26/20220.00B
Q4 20211/27/20220.00B
Q3 202110/21/20210.00B
Q2 20217/22/20210.00B
Q1 20214/22/20210.00B
Q4 20201/28/20210.00B
Q3 202010/22/20200.00B
Q2 20207/23/20200.00B
Q1 20204/23/20200.00B
Q4 20191/27/20200.00B
Q3 201910/17/20190.00B
Q2 20197/18/20190.00B
Q1 20194/25/20190.00B
Q4 20181/24/20193.73M
Q3 201810/17/20183.67M
Q2 20187/19/20183.75M
Q1 20184/19/20184.94M
Q4 20171/25/20184.93M
Q3 201710/19/20173.55M
Q2 20177/20/20174.31M
Q1 20174/20/20174.31M
Q4 20161/26/20173.71M
Q3 201610/20/20163.39M
Q2 20167/21/20162.65M
Q1 20164/21/20162.27M
Q4 20151/28/20162.74M
Q3 201510/22/20152.05M
Q2 20157/22/20151.23M
Q1 20154/21/20151.28M
Q4 20142/12/20151.41M
Q3 201410/28/20141.43M
Q2 20147/24/20141.34M
Q1 20144/24/20141.33M
Q4 20132/13/20141.40M
Q3 201310/23/20131.31M
Q2 20137/25/20131.16M
Q1 20134/25/20131.40M
Q4 20122/19/20131.52M
Quotes delayed 20 minutes

Email EnvelopeFree NURO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NeuroMetrix (NURO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NUVA Past Earnings
NUVL Past Earnings
NUWE Past Earnings
NVAX Past Earnings
NVIV Past Earnings
NVNO Past Earnings
NVOS Past Earnings
NVRO Past Earnings
NVST Past Earnings
NVTA Past Earnings

NURO Past Earnings Q&A

What was the best and worst NURO past earnings results?
For NeuroMetrix, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NURO past earnings result in our data set was 1.600/share posted in Q1 2018, while the lowest was in Q4 2013 when NURO posted -412.800/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2018 when NURO reported 4.94M in revenue, while the quarter with the lowest revenue in our data set was Q2 2013 at 1.16M of revenue.

  Suggested answer: There are 39 NURO past earnings results in our data set.

On this page we presented the NURO past earnings date information for NeuroMetrix. Reviewing that NURO Past Earnings for the company, we see that the highest past earnings result in our data set was in Q1 2018, when NURO posted gaap of 1.600/share. Meanwhile the lowest NURO past earnings result was in Q4 2013, when NURO posted gaap of -412.800/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2018 when NURO reported 4.94M in revenue, while the smallest revenue quarter was Q2 2013 when NURO reported 1.16M in revenue.

Any self directed investor doing their due diligence on NURO or any other given stock can benefit from researching all of the NeuroMetrix past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate NeuroMetrix past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NURO. Thanks for visiting, and the next time you need to research NURO past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: BST Dividend History, SKYW Insider Buying, VABK Next Dividend Date.

 

NURO Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.